Skip to main content

Table 7 Percentage increment in the experimental groups’ body weight for 30 days treatment period

From: Therapeutic potentials of Crataegus azarolus var. eu- azarolus Maire leaves and its isolated compounds

Group

Treatment (p.o.)

Day 0

Day 15

Day 30

I

1% w/v sodium CMC

211.3 ± 3.6

236.1 ± 4.3

(+11.9 ± 0.5)

253.2 ± 3.4

(+20.2 ± 0.4)

II

Cholesterol

209.3 ± 2.8

250.4 ± 3.6

(+19.8 ± 0.5)#

273.1 ± 4.6

(+30.5 ± 0.3)#

III

Cholesterol + lovastatin

212.4 ± 3.6

252.1 ± 2.4

(+18.7 ± 0.3)

272.1 ± 3.4

(+28.1 ± 0.6)

IV

Cholesterol + plant extract 250 mg/kg

211.8 ± 4.2

244.4 ± 5.1

(+15.4 ± 0.3)*

250.1 ± 3.5

(+18.1 ± 0.6)**

V

Cholesterol + plant extract 500 mg/kg

210.6 ± 5.3

241.1 ± 4.3

(+14.5 ± 0.2)*

247.8 ± 5.3

(+17.7 ± 0.8)\**

  1. # p < 0.01 vs group I; *, ** p < 0.05 and 0.01 vs cholesterol induced hyperlipidemic control group respectively